This is an Inequalities Network related event and also supported by our National & European Parliamentarians for Cancer Action group:
 |
 |
Programme
1600-1610: Welcome and introductions
- Matti Aapro, Immediate Past-President, European Cancer Organisation
- Mirjam Crul, Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and the Workforce Network, European Cancer Organisation
16:10-17:00: Part 1 - The Upcoming Revisions to the EU Pharmaceutical Regulations and What it Means for Cancer
16:10-16:25 - Current Status of the Pharmaceutical Regulations update & Providing Relevant Background
16:25-16:55: Unmet Medical Need - How to Better Define? How Might the Cancer Sector Benefit?
-
Kostas Stamatopoulos, Member, Research and European Affairs Committees, European Hematology Association
16:55-17:00: Summary and Conclusions from the Discussion
17:00-17:40: Part 2 - The Opportunities for Addressing Medicines Shortages in 2023
17:00-17:15: Setting the Scene - The Shortages Situation We Face
17:15-17:25: The EMA’s New Role on Medicines Shortages
17:25-17:35: Exchange on Next Steps
- Despoina Makridaki, Director of Professional Development, European Association of Hospital Pharmacists (EAHP)
17:35-17:40: Summary and Conclusions from the Discussion
17:40-18:20: Part 3 - The Application of the EU’s HTA Regulation and its Relevance to Cancer
17:40-17:55: What is the EU HTA Regulation? What Does it Mean for Cancer?
- Dirk Van den Steen, Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
17:55-18:05: How is the Progress of the Regulation so far? What’s Upcoming?
18:05-18:20: Exchange and Discussion on the HTA Regulation and What it Means for Cancer
- Robin Doeswijk, Head of European Affairs, European Hematology Association
18:20-18:30: Part 4 - Conclusions
- Tomislav Sokol MEP, Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Croatia
- Sara Cerdas MEP, Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
Speakers
-
Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
-
Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
-
Matti Aapro Immediate Past-President, European Cancer Organisation
-
Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
-
Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
-
Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association
Speakers
-
Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
-
Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
-
Matti Aapro Immediate Past-President, European Cancer Organisation
-
Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
-
Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
-
Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association
-
Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia Read Bio
-
Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal Read Bio
-
Matti Aapro Immediate Past-President, European Cancer Organisation
-
Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
-
Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2) Read Bio
-
Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association Read Bio
-
Despoina Makridaki Director, Professional Development, European Association of Hospital Pharmacists (EAHP) Read Bio
Speakers
-
Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
-
Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
-
Matti Aapro Immediate Past-President, European Cancer Organisation
-
Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
-
Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
-
Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association
Speakers
-
Tomislav Sokol MEP MEMBER, SPECIAL COMMITTEE ON THE COVID-19 PANDEMIC (COVI), and Member, Parliamentarians for Cancer Action, Croatia
-
Sara Cerdas MEP Member, Special Committee on the Covid-19 Pandemic (COVI), and Member, Parliamentarians for Cancer Action, Portugal
-
Matti Aapro Immediate Past-President, European Cancer Organisation
-
Mirjam Crul Board Member and Co-Chair of both the Special Network on the Impact of Covid-19 on Cancer and Workforce Network, European Cancer Organisation
-
Dirk Van den Steen Deputy Head of Unit, State of Health, European Semester, Health Technology Assessment (SANTE.C.2)
-
Kostas Stamatopoulos Member, Research and European Affairs Committees, European Hematology Association
